标题
CD133 in Breast Cancer Cells: More than a Stem Cell Marker
作者
关键词
-
出版物
Journal of Oncology
Volume 2019, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2019-09-17
DOI
10.1155/2019/7512632
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Potentialization of anticancer agents by identification of new chemosensitizers active under hypoxia
- (2019) Sébastien Marx et al. BIOCHEMICAL PHARMACOLOGY
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- CD133: beyond a cancer stem cell biomarker
- (2018) Amir Barzegar Behrooz et al. JOURNAL OF DRUG TARGETING
- Management of patients with acute promyelocytic leukemia
- (2018) Sabine Kayser et al. LEUKEMIA
- Nuclear Localization of Cancer Stem Cell Marker CD133 in Triple-Negative Breast Cancer: A Case Report
- (2018) Monica Cantile et al. TUMORI
- Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling
- (2018) Wei Zheng et al. BIOSCIENCE REPORTS
- Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
- (2018) Yasamin Al-Qassab et al. BMC CANCER
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
- (2018) Chitra Joseph et al. BREAST CANCER RESEARCH AND TREATMENT
- CD133 as a regulator of cancer metastasis through the cancer stem cells
- (2018) Geou-Yarh Liou INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a
- (2018) Valeria Bertagnolo et al. MOLECULAR CARCINOGENESIS
- Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
- (2017) Guilhem Bousquet et al. Oncotarget
- Detection of Putative Stem-cell Markers in Invasive Ductal Carcinoma of the Breast by Immunohistochemistry
- (2017) Rodrigo V. Oliveira et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer
- (2016) E. Latorre et al. CANCER RESEARCH
- PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential
- (2016) Federica Brugnoli et al. MOLECULAR CARCINOGENESIS
- KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties
- (2016) S K Saha et al. ONCOGENE
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Notch1 directly induced CD133 expression in human diffuse type gastric cancers
- (2016) Hidetomo Konishi et al. Oncotarget
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
- (2015) E K Park et al. Cell Death & Disease
- Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
- (2015) Francesca Collina et al. Biomed Research International
- The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
- (2014) Joseph C. Walsh et al. ANTIOXIDANTS & REDOX SIGNALING
- Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events
- (2014) Carolin Bock et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
- (2014) Danfang Zhang et al. Molecular Cancer
- CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
- (2013) Rosa Nadal et al. INTERNATIONAL JOURNAL OF CANCER
- CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells
- (2013) KRISTINA S. LEHNUS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness
- (2013) Federica Brugnoli et al. Molecular Cancer
- Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors
- (2013) Shunsuke Ohnishi et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer
- (2012) Naofumi Kagara et al. AMERICAN JOURNAL OF PATHOLOGY
- Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres
- (2012) Silvia Borgna et al. CELL CYCLE
- A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro
- (2012) Jinmin Sun et al. CLINICAL & EXPERIMENTAL METASTASIS
- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity
- (2012) Margaret J. Currie et al. HUMAN PATHOLOGY
- Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer
- (2012) Maurizio Di Bonito et al. Journal of Breast Cancer
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
- (2012) Naoki Aomatsu et al. PLoS One
- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland
- (2011) Lisa H. Anderson et al. DEVELOPMENTAL DYNAMICS
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
- (2011) A. J. Armstrong et al. MOLECULAR CANCER RESEARCH
- Phenotypic Heterogeneity of Breast Cancer Stem Cells
- (2011) Aurelio Lorico et al. Journal of Oncology
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
- (2010) Matthew J. Meyer et al. CANCER RESEARCH
- Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche
- (2010) Ahmed Mohyeldin et al. Cell Stem Cell
- Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β
- (2010) Hanning You et al. HEPATOLOGY
- Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
- (2010) Laura D'Anello et al. Molecular Cancer
- The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases
- (2009) Dominique Boivin et al. BIOCHEMISTRY
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CD133 stem cells in adult human brain
- (2008) H. T. Hassan et al. JOURNAL OF NEURO-ONCOLOGY
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now